Contribution of stem cells to neointimal formation of decellularized vessel grafts in a novel mouse model

American Journal of Pathology

Volumn 181, Issue 1, 2012, Pages 362-373

  Tsai, Tsung Neng ^a   Kirton, John Paul ^a   Campagnolo, Paola ^a   Zhang, Li ^b   Xiao, Qingzhong ^c   Zhang, Zhongyi ^a   Wang, Wen ^d   Hu, Yanhua ^a   Xu, Qingbo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIBODY; PLATELET DERIVED GROWTH FACTOR BB; STEM CELL ANTIGEN 1; STEM CELL FACTOR; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BLOOD VESSEL GRAFT; CAROTID ARTERY; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CLONOGENESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPLANT; IN VITRO STUDY; MONOCYTE; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER; STEM CELL TRANSPLANTATION;

ANIMALS; ANTIGENS, LY; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CAROTID STENOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GRAFT OCCLUSION, VASCULAR; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; STEM CELLS; TISSUE SCAFFOLDS; TRANSPLANTATION CHIMERA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862667453     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.03.021     Document Type: Article

References (41)

1. Schwartz SM: The intima: a new soil. Circ Res 1999, 85:877-879
2. Ross R, Glomset J, Harker L: Response to injury and atherogenesis. Am J Pathol 1977, 86:675-684
3. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M: Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001, 7:382-383
4. Sata M: Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 2003, 13:249-253
5. Bentzon JF, Sondergaard CS, Kassem M, Falk E: Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 2007, 116:2053-2061
6. Bentzon JF, Weile C, Sondergaard CS, Hindkjaer J, Kassem M, Falk E: Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 2006, 26:2696-2702
7. Hagensen MK, Shim J, Thim T, Falk E, Bentzon JF: Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 2010, 121:898-905
8. Torsney E, Xu Q: Resident vascular progenitor cells. J Mol Cell Cardiol 2011, 50:304-311
9. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409
10. Schaner PJ, Martin ND, Tulenko TN, Shapiro IM, Tarola NA, Leichter RF, Carabasi RA, Dimuzio PJ: Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 2004, 40:146-153
11. Moessler H, Mericskay M, Li Z, Nagl S, Paulin D, Small JV: The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development 1996, 122:2415-2425
12. Schlaeger TM, Bartunkova S, Lawitts JA, Teichmann G, Risau W, Deutsch U, Sato TN: Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A 1997, 94:3058-3063
13. Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, Xu Q: Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998, 153:1301-1310
14. Dietrich H, Hu Y, Zou Y, Dirnhofer S, Kleindienst R, Wick G, Xu Q: Mouse model of transplant arteriosclerosis: role of intercellular adhesion molecule-1. Arterioscler Thromb Vasc Biol 2000, 20:343-352
15. Dietrich H, Hu Y, Zou Y, Huemer U, Metzler B, Li C, Mayr M, Xu Q: Rapid development of vein graft atheroma in ApoE-deficient mice. Am J Pathol 2000, 157:659-669
16. Hu Y, Davison F, Ludewig B, Erdel M, Mayr M, Url M, Dietrich H, Xu Q: Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002, 106:1834-1839
17. Hu Y, Mayr M, Metzler B, Erdel M, Davison F, Xu Q: Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res 2002, 91:e13-e20
18. Mayr U, Mayr M, Li C, Wernig F, Dietrich H, Hu Y, Xu Q: Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice. Circ Res 2002, 90:197-204
19. Hu Y, Zou Y, Dietrich H, Wick G, Xu Q: Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. Circulation 1999, 100:861-868
20. Hu Y, Baker AH, Zou Y, Newby AC, Xu Q: Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model. Arterioscler Thromb Vasc Biol 2001, 21:1275-1280
21. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K: Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000, 408:92-96
22. Torsney E, Mayr U, Zou Y, Thompson WD, Hu Y, Xu Q: Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. Circ Res 2004, 94:1466-1473
23. Xu Q: Mouse models of arteriosclerosis: from arterial injuries to vascular grafts. Am J Pathol 2004, 165:1-10
24. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM: Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res 1993, 73:223-231
25. Schwartz RS, Henry TD: Pathophysiology of coronary artery restenosis. Rev Cardiovasc Med 2002, 3(Suppl 5):S4-S9
26. Detmers PA, Hernandez M, Mudgett J, Hassing H, Burton C, Mundt S, Chun S, Fletcher D, Card DJ, Lisnock J, Weikel R, Bergstrom JD, Shevell DE, Hermanowski-Vosatka A, Sparrow CP, Chao YS, Rader DJ, Wright SD, Pure E: Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol 2000, 165:3430-3435
27. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL: ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 1994, 14:605-616
28. TCampbell JH, Campbell GR: The role of smooth muscle cells in atherosclerosis. Curr Opin Lipidol 1994, 5:323-330
29. Ross R, Glomset JA: The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 1976, 295:369-377
30. Ross R, Glomset JA: The pathogenesis of atherosclerosis (second of two parts). N Engl J Med 1976, 295:420-425
31. Atkinson C, Horsley J, Rhind-Tutt S, Charman S, Phillpotts CJ, Wallwork J, Goddard MJ: Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin. J Heart Lung Transplant 2004, 23:427-435
32. Caplice NM, West MJ, Campbell GR, Campbell J: Inhibition of human vascular smooth muscle cell growth by heparin. Lancet 1994, 344:97-98
33. Hillebrands JL, Klatter FA, Rozing J: Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler Thromb Vasc Biol 2003, 23:380-387
34. Hirschi KK, Majesky MW: Smooth muscle stem cells. Anat Rec A Discov Mol Cell Evol Biol 2004, 276:22-33
35. Sata M, Maejima Y, Adachi F, Fukino K, Saiura A, Sugiura S, Aoyagi T, Imai Y, Kurihara H, Kimura K, Omata M, Makuuchi M, Hirata Y, Nagai R: A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 2000, 32:2097-2104
36. Iwata H, Manabe I, Fujiu K, Yamamoto T, Takeda N, Eguchi K, Furuya A, Kuro OM, Sata M, Nagai R: Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation 2010, 122:2048-2057
37. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q: Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004, 113:1258-1265
38. Gawaz M, Langer H, May AE: Platelets in inflammation and atherogenesis. J Clin Invest 2005, 115:3378-3384
39. McEver RP: Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001, 86:746-756
40. Bavry AA, Bhatt DL: Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. Lancet 2008, 371:2134-2143
41. Laitinen M, Zachary I, Breier G, Pakkanen T, Hakkinen T, Luoma J, Abedi H, Risau W, Soma M, Laakso M, Martin JF, Yla-Herttuala S: VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther 1997, 8:1737-1744